Confident mature woman, writer using laptop computer, taking notes

Vaccination Delivery Planner: From Eligible Patients to Delivery

Plan your Shingles National Immunisation Programme (NIP) delivery with confidence. The Shingles Vaccination Delivery Planner helps you assess capacity, model delivery scenarios, and estimate how quickly you can achieve your vaccination targets.

Adverse events reporting and prescribing information can be found at the bottom of the page.

Healthcare professionals have been consulted by GSK and received honorarium.

Have you:

  • Run a system search and generated your eligible patient list?
  • Identified more eligible patients than expected?
  • Wondered how many clinics or appointments you'll need?
  • Been unsure how quickly patients can be vaccinated?

The Vaccination Delivery Planner has been designed to help you take the next step by turning your eligible patient numbers into practical delivery plans, tailored to your practice team. By combining eligible patient population data and your available workforce, the planner estimates the number of appointments required to achieve your goals, supporting confident workforce planning, resource allocation and programme delivery.

The Vaccination Delivery Planner helps you turn patient numbers into a practical delivery plan.

Using the planner, you can:

Tailor outputs to the number of eligible patients in your practice

Use the number of eligible patients identified through your searches to understand the workforce capacity and appointment volumes required to deliver vaccination within your chosen timeframe.

Understand how your existing workforce can support delivery

Estimate the number of clinics and appointments required by your workforce to vaccinate your eligible patient population within your chosen timeframe.

Plan delivery with confidence

View the vaccination activity required per month, week and working day to support implementation and monitoring of the Shingles National Immunisation Programme.

Why plan ahead?

Many eligible patients remain unvaccinated, new patients continue to become eligible, and the shingles NIP can be delivered all year round.1-5 Regular planning and monitoring can help support vaccine uptake and avoid missed vaccination opportunities.

Shingles Vaccination Delivery Planner

Use this interactive tool to plan how you can deliver your shingles vaccination goals with your available workforce. Enter your eligible patient numbers, desired timeframe and available number of vaccinators to determine the capacity required to deliver the programme. You can also model different delivery timeframes to understand what is achievable with your existing resource.

Calculate Delivery Plan

Enter the total number of eligible patients identified through your searches.

Enter the number of months in which you want to vaccinate these patients. Decimal values can be used to reflect weeks (e.g 2.5 = 2 months and 2 weeks).

Decimal values can be used to reflect part-time vaccinators (e.g. 0.5 = half of a vaccinator's available clinic time).

Your Output

To vaccinate eligible patients within months, a team of vaccinators would each need to administer approximately:

vaccinations per month
vaccinations per week
vaccinations per working day

No information entered will be saved or stored by GSK. This tool provides an estimation only. Other factors outside of those inputted, for example change-over time between individuals getting their vaccinations or vaccinators taking time between vaccinations to complete documentation and/or prepare for their next vaccination are not incorporated. This tool assumes a 5-day working week.

Shingles and its complications, which can be severe and long-lasting, may result in patients repeatedly returning to the clinic, which in turn impacts time, resources and capacity.6-8

Not only does a planned, proactive approach help protect* patients from shingles, but it can also support your practice and the wider healthcare system by reducing GP appointments and hospitalisations.1,8-9

In addition, practices can receive an item of service fee per dose administered to eligible patients: £10.06 in England, £10.03 in Wales, and £10 in Northern Ireland, and practices in England have the opportunity to obtain up to 10 Quality and Outcomes Framework (QOF) points.10-14**

Set your target

Set your target

Calculate your capacity

Calculate your capacity

Plan your delivery

Plan your delivery

Small increases in vaccination activity each week can help ensure eligible patients are protected earlier

Next steps: Putting your delivery plan into practice

Turn your results into action.

The next step is to put your delivery plan into practice by scheduling clinics, allocating resources and inviting eligible patients for vaccination.

Using your capacity estimates to inform clinic planning can help ensure that eligible patients have the opportunity to be vaccinated, support uptake ambitions and enable earlier protection against shingles.

Effective implementation of the shingles National Immunisation Programme (NIP) could substantially reduce the burden of shingles on healthcare services.8

To support the delivery and implementation of the Shingles National Immunisation Programme (NIP), access practical resources including the NIP Planning Tool, Implementation Checklist and guidance on inviting your patients.

NIP planning tool and clinic checklist

NIP Planning Tool and Clinic Checklist

Explore our handy infographic filled with practical advice and guidance, and a downloadable checklist detailing key steps for implementation.

NIP planning tool and clinic checklist
Healthcare professional applying cotton pad on patient’s arm

Supporting the Patient Journey

Use our Patient Support Materials to address pain-points that you might have when communicating the importance of the shingles vaccination.

Resources for Patient Support

* The most frequently reported adverse reactions are headache, gastrointestinal symptoms (including nausea, vomiting, diarrhoea and/or abdominal pain), myalgia, injection site reactions (such as pain, redness, swelling), fatigue, chills and fever. Please refer to the SHINGRIX (herpes zoster vaccine, recombinant adjuvanted) SmPC for a full list of adverse events9

** A maximum of 10 points are awarded if at least 60% of your patients who turned 80 years old in the preceding 12 months, received a shingles vaccine between the ages of 70 and 79 years, in line with the Shingles National Immunisation Programme.

References
  1. UKHSA Green Book: Shingles: the green book chapter. Updated 12 August 2025.
  2. UK Health Security Agency. Shingles vaccine coverage in England: annual report September 2024 to August 2025. Updated 28 May 2026.
  3. Public Health Scotland. Shingles vaccine coverage: PHS vaccination surveillance dashboard. Published 7 October 2025.
  4. Public Health Agency Health Protection Surveillance(Vaccines). Shingles vaccination surveillance in Northern Ireland: end of programme year report 2023/2024. Published 6 May 2025.
  5. Public Health Wales Health Protection. Shingles Vaccination - All Wales. Updated 11th May 2026.
  6. UK NICE Clinical Knowledge Summaries, 2026. Shingles: What are the complications?
  7. UK NICE Clinical Knowledge Summaries, 2026. Shingles: What are the clinical features of shingles?
  8. Hunjan M, Curran D, Marijam A, et al. Infect Dis Ther 2025; 14: 105-119.
  9. SHINGRIX. Summary of Product Characteristics (United Kingdom)
  10. NHS England. Shingles toolkit. Published August 2023.
  11. Welsh Government. Expansion of shingles immunisation for severely immunosuppressed people aged 18 to 49 (WHC/2025/028). Updated 14 August 2025.
  12. Welsh Health Circular. WHC (2023) 024. Change of vaccine and cohort expansion for shingles vaccination programme (from September 2023). Published 28 June 2023.
  13. Letter from the CMO. HSS(MD)29/2025. Department of Health NI. Shingles Vaccination Programme 2025/2026.
  14. NHS England. Quality and outcomes framework guidance for 2026/2027. Published March 2026.

September 2026 | PM-GB-HZU-WCNT-260005

For the SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.